FDA approves Teva pain medication for long-term use
The U.S. Food and Drug Administration has approved Vantrelatm, a pain medication designed by Teva Pharmaceutical Ltd., for long-term use in time-released capsules. Read More »
Study shows excessive use of acetaminophen can lead to hearing loss
A recent study has shown that using acetaminophen, an ingredient commonly found in painkillers, over a long period of time leads to an increased risk of hearing loss in adults. Read More »
Mylan CEO presents at annual health conference
Mylan CEO Heather Bresch presented at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco. Read More »
European Commission OK's Gilead drug for Hepatitis C
The European Commission has granted Gilead Sciences Inc. marketing authorization for Vemlidy, a drug used in the treatment of people suffering from chronic Hepatitis B infections. Read More »
FDA approves application for new breast cancer treatment
The U.S. Food and Drug Administration recently approved a license application for Mylan Biotechnology, in collaboration with Biocon, for the use of biosimilar tratuzumab in the treatment of breast cancer. Read More »
Gilead Sciences awards $22 million in HIV research funds
Gilead Sciences Inc., has awarded more than $22 million in grants to help fund HIV cure programs. Read More »
Proposed CMS antimicrobial program hits delay with presidential transition
The Centers for Medicare and Medicaid Services hit a snag last week in seeking approval of a proposal that requires hospitals to have antimicrobial stewardship programs participating in Medicare and Medicaid programs. Read More »
Study seeks data on generic medication preferences
Results from a November study have raised concerns about how pharmacists substitute generic medications for their name brand counterparts. Read More »
Telecommunications can offer remote access to some health services
A new trend in communications is on the verge of creating a health care revolution, according to one rehabilitation clinic spokesperson. Read More »
CDC promotes pharmacists' role in helping patients with hypertension
The Centers for Disease Control and Prevention have released new resources to encourage pharmacists to take a more active role in the management of hypertension among their patients. Read More »
Ovarian cancer treatment receives FDA approval
Ovarian cancer patients who have a sensitivity to chemotherapy will soon have another option to treat their disease as the U.S. Food and Drug Administration has approved Avastin as an alternative to or supplement for chemotherapy. Read More »
FDA approves review of Genentech drug to treat advanced bladder cancer
Biotech group Genentech scored a big victory as the U.S. Food and Drug Administration has granted a priority review of the company’s newest cancer-treating drug, Tecentriq. Read More »
Treatment for extrerme nearsightedness receives FDA approval
The U.S. Food and Drug Administration has approved the use of Lucentis, created by biotech company Genentech, for people suffering with severe nearsightedness. Read More »
Mylan purchases popular cold medication Cold-Eeze
Mylan N.V, a major distributor of over the counter medications, has acquired popular cold medication Cold-Eeze from ProPhase Labs Inc. Read More »
FDA approves Sangamo's drug application for hemophilia A treatment
The U.S. Food and Drug Administration has approved Sangamo BioSciences Inc.'s Investigational New Drug Application for the SB-525 gene therapy program for patients with hemophilia A. Read More »
Custopharm acquires acetaminophen, testosterone products from Perrigo
Custopharm Inc., a U.S. producer of generic injectable devices, has acquired two Paragraph IV abbreviated new drug application products from Perrigo Co. PLC. Read More »
Alexion receives orphan drug designation for PNH treatment
The U.S. Food and Drug Administration granted orphan drug designation to Alexion Pharmaceuticals for ALXN1210, a drug for treating patients with paroxysmal nocturnal hemoglobinuria. Read More »
Acucela treatment receives FDA orphan drug designation
The U.S. Food and Drug Administration granted orphan drug designation to Acucela's leading drug candidate emixustat hydrochloride, which was created to treat Stargardt disease. Read More »
Dova Pharmaceuticals taps Sapir as new CEO
Dova Pharmaceuticals Inc., a clinical, late-stage company, recently named Alex Sapir as its new CEO. Read More »
Amorsa, Janssen partner on nervous system disorder treatment
Amorsa Therapeutics, a neuropharmaceutical company specializing in treating nervous system disorders, has entered a partnership with Janssen Pharmaceuticals Inc. Read More »
Alerts Sign-up